I do think there’s a lot of reason to be a lot more optimistic...

I do think there’s a lot of reason to be a lot more optimistic about the potential of success than it seems the market currently is.

However if for one second we be ultra pessimistic and ascribe a probability of 50% (far below the average 60% success rate for P3 trials), that’s still a coin toss bet. Don’t know about you all, but given I see this easily trading in the upper end of $5-$10 by the time approval comes, so given the risk/return that’s still a coin I’d be willing to toss. Any high probability of success just makes it even more appealing.

The current market cap is far too low a valuation currently for even the most pessimistic of estimates of probability of success IMO, this’ll likely be earning in profit each year the current market cap of the company soon after approval with a good enough improvement in BCVA